Fluconazole Prophylaxis in HIV Disease, Revisited

Published in: Clinical Infectious Diseases, v. 41, no. 15, Editorial Commentary, Nov. 2005, p. 1481-1482

Posted on RAND.org on January 01, 2005

by Samuel A. Bozzette

Read More

Access further information on this document at www.journals.uchicago.edu

This article was published outside of RAND. The full text of the article can be found at the link above.

Editorial comment on a study of the use of fluconazole prophylaxis for mucosal candidal infection in HIV disease, and the question of emerging drug resistance associated with its use.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.